Skip to content
Screener

G&A at other companies

Encompass Health Corporation logo
Encompass Health CorporationEHC
$58.2M+11.3%
HCA Healthcare logo
HCA HealthcareHCA
$148M+13.8%
ARD
Ardent Health PartnersARDT
$48.6M+39.3%
CONMED logo
CONMEDCNMD
$31.14M-5.7%
Astrana Health logo
Astrana HealthASTH
$61.74M+40.6%
PACS Group logo
PACS GroupPACS
$112.32M+13.8%

Segments

By segment

See full
Surgical Facilities$39.3M+9.2%

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.95B-32.1%
Enterprise value$6.82B-9.2%
P/S0.6×-0.3×

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001638833-26-000046
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Lease expense23.020.8
Other operating expenses58.843.6
Cost of revenues650.7614.1
General and administrative expenses39.336.0
Depreciation and amortization38.536.3
Transaction and integration costs15.624.7
Net loss on disposals, consolidations and deconsolidations4.36.4
Equity in earnings of unconsolidated affiliates(4.1)(5.6)

Item 1. Financial Statements

FAQ

What is Surgery Partners, Inc.'s G&A?
Surgery Partners, Inc. (SGRY) reported G&A of $39.3M in Q1 2026.
How has Surgery Partners, Inc.'s G&A changed year-over-year?
Surgery Partners, Inc.'s G&A increased by 9.2% year-over-year, from $36M to $39.3M.
What is the long-term trend for Surgery Partners, Inc.'s G&A?
Over 4 years (2021 to 2025), Surgery Partners, Inc.'s G&A has grown at a 3.3% compound annual growth rate (CAGR), from $104M to $118.2M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Surgery Partners, Inc.'s g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude